Your browser doesn't support javascript.
loading
Identification of circulating monocytes as producers of tuberculosis disease biomarker C1q.
Niewold, Paula; Dijkstra, Douwe J; Cai, Yi; Goletti, Delia; Palmieri, Fabrizio; van Meijgaarden, Krista E; Verreck, Frank A W; Akkerman, Onno W; Hofland, Regina W; Delemarre, Eveline M; Nierkens, Stefan; Verheul, Marije K; Pollard, Andrew J; van Dissel, Jaap T; Ottenhoff, Tom H M; Trouw, Leendert A; Joosten, Simone A.
Afiliação
  • Niewold P; Department of Infectious Diseases, Leiden University Medical Center, Leiden, the Netherlands. p.niewold@lumc.nl.
  • Dijkstra DJ; Department of Immunology, Leiden University Medical Center, Leiden, the Netherlands.
  • Cai Y; Guangdong Key Laboratory of Regional Immunity and Diseases, Department of Pathogen Biology, Shenzhen University Medical School, Shenzhen, China.
  • Goletti D; Translational Research Unit, Department of Epidemiology and Preclinical Research, National Institute for Infectious Diseases, Rome, Italy.
  • Palmieri F; Respiratory Infectious Diseases Unit, Clinical Department, National Institute for Infectious Diseases, Rome, Italy.
  • van Meijgaarden KE; Department of Infectious Diseases, Leiden University Medical Center, Leiden, the Netherlands.
  • Verreck FAW; Section of TB Research & Immunology, Department of Parasitology, Biomedical Primate Research Centre (BPRC), Rijswijk, the Netherlands.
  • Akkerman OW; Department of Pulmonary Disease and Tuberculosis, University of Groningen, Groningen, the Netherlands.
  • Hofland RW; Tuberculosis Center Beatrixoord, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Delemarre EM; Department of Pulmonary Diseases and Tuberculosis, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Nierkens S; Center for Translational Immunology, UMC Utrecht, Utrecht, the Netherlands.
  • Verheul MK; Center for Translational Immunology, UMC Utrecht, Utrecht, the Netherlands.
  • Pollard AJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • van Dissel JT; Oxford Vaccine Group, Department of Pediatrics, University of Oxford and NIHR Oxford Biomedical Research Centre, Oxford, UK.
  • Ottenhoff THM; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, 3720 BA, The Netherlands.
  • Trouw LA; Oxford Vaccine Group, Department of Pediatrics, University of Oxford and NIHR Oxford Biomedical Research Centre, Oxford, UK.
  • Joosten SA; Department of Infectious Diseases, Leiden University Medical Center, Leiden, the Netherlands.
Sci Rep ; 13(1): 11617, 2023 07 18.
Article em En | MEDLINE | ID: mdl-37464009
ABSTRACT
Tuberculosis (TB) is a prevalent disease causing an estimated 1.6 million deaths and 10.6 million new cases annually. Discriminating TB disease from differential diagnoses can be complex, particularly in the field. Increased levels of complement component C1q in serum have been identified as a specific and accessible biomarker for TB disease but the source of C1q in circulation has not been identified. Here, data and samples previously collected from human cohorts, a clinical trial and a non-human primate study were used to identify cells producing C1q in circulation. Cell subset frequencies were correlated with serum C1q levels and combined with single cell RNA sequencing and flow cytometry analyses. This identified monocytes as C1q producers in circulation, with a pronounced expression of C1q in classical and intermediate monocytes and variable expression in non-classical monocytes.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose / Monócitos Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose / Monócitos Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article